mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0007 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.0008 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.002 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Gefitinib |
FIMM |
pan-cancer |
AAC |
-0.5 |
0.003 |